FDA Approves Alzheimer’s Blood Test
The U.S. Food and Drug Administration has given marketing clearance to the Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, a blood test to help diagnose Alzheimer’s disease for adults 55 and older who are showing signs and symptoms of the disease. It is the first test to be approved to aid in the early detection of the disease in the United States.
Blood Test Can Predict How Long Vaccine Immunity Will Last
A study led by researchers at Stanford Medicine has shown that variation in vaccine durability can, in part, be attributed to a type of blood cell called megakaryocytes, typically implicated in blood clotting.
FDA Approves First Over-the-Counter Combo Flu and COVID Test Outside of Emergency Use
The U.S. Food and Drug Administration (FDA) has authorized the first over-the-counter combination COVID-19 and influenza test, the Healgen Rapid Check COVID-19/Flu A&B Antigen Test, outside of emergency use.
Blood Test Predicts Multiple Sclerosis Years Before Symptoms Appear
Researchers at the University of California, San Francisco, have identified a specific pattern of autoantibodies in the blood that precedes the clinical onset of multiple sclerosis.
Study Shows New Blood Test May Predict Alzheimer’s Risk
A recent study has found that a commercially available plasma p-tau217 (phosphorylated tau 217) immunoassay accurately identified biological Alzheimer’s disease (AD).
Blood-Based Biomarkers Can Detect Alzheimer’s 10 Years Before Disease Onset
A new study shows that a protein called glial fibrillary acidic protein is a possible biomarker for very early stages of Alzheimer’s.
New Test Identifies Patients at Risk of Severe COVID-19
U.S. scientists have developed a new genomic test that can predict a patient’s risk of developing severe COVID-19, an advance that could help doctors quickly begin tailored treatment.
FDA Approves New Gene Therapy Treatment for Rare Blood Disorder
FDA has given fast track approval for Bluebird Bio’s Zynteglo, a treatment designed to tackle the rare condition known as transfusion-dependent beta-thalassemia (TDBT).
New Program Launched to Identify Autoimmune Disease Therapies
A cross-disciplinary coalition of experts from academic centers across the United States is partnering with NIH, FDA, pharmaceutical companies and nonprofit organizations to identify new targets for therapies for autoimmune-meditated diseases.
Virus Identified as Cause of Multiple Sclerosis
A new study shows the Epstein-Barr virus (EBV) is essential for the development of multiple sclerosis (MS).
